9th Annual Biomarkers Congress

Peptides: University of California

Total Score People Score Events Score
42 37 17
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Peter W Laird
BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Martin McMahon
Classification and Pathogenesis of Liver Cancers Co-Chairpersons: Josep Llovet, Mt. Sinai School of Medicine, New York, NY, and Jessica Zucman-Rossi, Inserm, Paris, France Michael Karin
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Claudia Petritsch
Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA Kevan M Shokat
Pediatric Cancer: From Susceptibility to Targeted Therapies Co-Chairpersons: Katherine K. Matthay, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, and John M. Maris, Children's Hospital of Philadelphia, Philadelphia, PA David H Rowitch
Epithelial Stem Cells, Morphogenesis, and Cancer Chairperson: Ian G. Macara, University of Virginia School of Medicine, Charlottesville, VA Lindsay Hinck
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Martin McMahon
Nuclear Topology and Transcription Factors: Defining the Architecture of Normal and Malignant Cells Chairperson: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY Bing Ren
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Zena Werb
Complementing Angiogenesis Inhibitor Actions on Tumors Donald M. McDonald, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Donald M. McDonald
Advances in High-Resolution Optical Microscopy Chairperson: Jan T. Liphardt, University of California, Berkeley, CA Jan T. Liphardt
Measuring Metabolism in Cancer Chairperson: Ralph J. DeBerardinis, UT Southwestern Medical Center, Dallas, TX Sabrina M. Ronen
Using Switchable Mouse Genetics to Identify Cancer Targets Gerard I. Evan, University of Cambridge, Cambridge, United Kingdom Gerard I Evan
Transdisciplinary Cancer Research Teams: If You Build It, Will They Come? Chairperson: Julie A. Ross, University of Minnesota Masonic Cancer Center, Minneapolis, MN Joseph L. Wiemels
Small Animal Imaging in Cancer Research Chairperson: H. Charles Manning, Vanderbilt University, Nashville, TN Charles F. Caskey
August 14, 2011 Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation and Cancer Adaptive Immunity and Tumor-Associated Macrophages Lisa M Coussens
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Immunity in Respiratory Tract (X6) | Short Talk: Lung Surveillance Revealed by Two-Photon Live Imaging Emily E. Thornton
January 12, 2011 Antibodies for the 21st Century Engineered Antibodies and Molecular Imaging: Shedding Light on Drug Development Anna M Wu
Antibody Fusion Proteins for the Treatment of Malignancy Sherie Morrison
May 17, 2010 Phage and Yeast Display of Antibodies and Proteins Phage Display Traps for Protein Conformation and Specific Composition Jim Wells
April 30, 2010 Drug Story In Vivo Imaging Technologies Using Engineered Antibodies Anna M Wu
Metabolic Biotinylation of Recombinant Antibody by Biotin Ligase Retained in the Endoplasmic Reticulum Bhaswati Barat
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Phage Display and Engineering of Membrane Proteins Gregory A Weiss
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Chemical genetic dissection of protein and lipid kinase regulatory networks Kevan M Shokat
August 26, 2009 Affinity Tag Protein Purification Element Coded Affinity Tags Claude F. Meares
January 25, 2009 17th International Symposium on Regulatory Peptides Plenary Lecture (Lecture 30 min and 10 min discussion): Session 1 Olivier Civelli
GPCR Trafficking :Session 2 N. Bunnett
General Discussion with the participation of Speakers and Chairs of Session 1 and 2: Olivier Civelli, N. Bunnett
Plenary Lecture : Session 8 Martin Martin
General Discussion with the participation of Speakers and Chairs of Session 8 and 9 on Endocrine cell development Martin Martin
December 7, 2008 Antibody Engineering Antibodies: Versatile Proteins for Multiple Applications Sherie Morrison
Session VIII: Mechanism of Antibody Action Revisited : Chairperson's Opening Remarks James D Marks
Anti-Human Transferrin Receptor Avidin Fusion Protein: A Molecule Capable of a Two-Pronged Attack Against Malignant Cells through Toxin Delivery and Direct Induction of Apoptosis Manuel L Penichet
Selection of Anti-CD22 Antibodies Based on Physiology and Epitope Joseph M Tuscano
How Antibody Combinations Synergize to Potently Neutralize Botulinum Neurotoxins James D Marks
May 1, 2008 Engineering Protein Therapeutics for Delivery Design of Recombinant G-CSF-Transferrin Fusion Proteins for Oral Delivery Wei Chiang Shen
May 1, 2008 10th Annual Alzheimer’s Conference Conference Chairman’s Welcome Franz Hefti
April 27, 2008 Phage Display of Antibodies and Peptides Phage-Displayed Selections and Screens with Terpene Synthases Gregory A Weiss
April 27, 2008 Phage Display of Antibodies and Peptides Phage-Displayed Selections and Screens with Terpene Synthases Gregory A Weiss
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Using Unnatural Amino Acids to Probe Neuroreceptors and Ion Channels Dennis A. Dougherty
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaohong Zhang
session 2: Deacetylation of cortactin by SIRT1 promotes ovarian and breast cancer cell migration (16:45-17:05) Dr. Xiaohong Zhang
Session 4: (Part One) Anti-Infectious Drug Discovery & Development (I) (Part Two) RNAi & Gene: Applications in Drug Discovery and Therapeutics (13:30-17:05) Dr. Victoria V. Lunyak
Session 4: Diving into the DNA Dumpster: SINE B2 Repeat Transcription is Responsible for the Organization of the Growth Hormone Gene Locus in Mouse Development (16:20-16:40) Dr. Victoria V. Lunyak
Session 5: Liver Disease Drug Discovery & Development and Innovative Therapeutics (09:00-12:10) Dr. Bangyan Stiles
Session 5: Discovery of New Therapeutic Targets Using Liver Pten Deletion Animal Model (10:40-11:00) Dr. Bangyan Stiles
Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Jianyu Rao
Session 7: Cancer Chemoprevention and Biomarkers (10:40-11:00) Jianyu Rao
Session 14: Cardiovascular and Heart Disease Drug Discovery & Development to Innovative Therapeutics (13:30-17:30) Ernst R. Schwarz
Session 14: A Novel Aqueous Alprostadil Formulation with Excellent Superficial Skin Penetration but without Hypersensitivity or Skin Irritation for the Treatment of Female Sexual Arousal Disorder (14:45-15:10) Ernst R. Schwarz
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.